AARC Explores 2022

AARC Explores

Say hello to AARC Explores, a 10-video annual series that offers an in-depth exploration of recent scientific advancements in respiratory care.

2022 AARC Explores Overview

Complete 2022 Series
Nonmember Price $500
Member Price $400
Members save $100.
Complete 2022 Series with License
Nonmember Price $600
Member Price $500
Members save $100.
Individual Pathway Videos
Nonmember Price $75
Member Price $50

Members save $25.
Single videos are only available as each topic is released.

What is AARC Explores?

AARC Explores delivers professional, continuing education to respiratory therapy departments that is convenient, affordable, and on-demand. Departments can provide up to 10 hours of CRCE to their staff, for one low price. There’s no better way to provide department-wide education to your staff than with AARC Explores!

How it Works

  • A department representative agrees to serve as the “proctor” and purchases either the “Series”, a “License” or “Individual Videos”.
    • Individual hospital departments may purchase the “Complete 2022 Series”.
    • Hospital/health systems may leverage their size and purchase the “Complete 2022 Series with License”.
    • Individual videos may also be purchased, but the bundled series provides the most savings.
  • Starting in March, your proctor will receive monthly access to new videos, released through December 2022.
  • These on-demand videos may be accessed by any member of the department — at one low price.
  • The proctor is responsible for maintaining a course roster for each educational video and upon completion, must submit it to the AARC for processing.
  • Course credit will automatically be applied to the CRCE Transcript for all AARC members.

Frequently Asked Questions

Q1: I’m part of a 5-hospital system. Which product do I purchase?
A1: The “Complete 2022 Series w/ License” gives your 5-hospital system a license to provide on-demand content to any respiratory therapist employed at any of the 5 hospitals. Each hospital will need to have a designated course proctor.
Q2: My department has 120 RTs in it. Is there a limit on how many people can take advantage of AARC Explores?
A2: No. The more employees there are, the more affordable AARC Explores becomes. If all 120 RTs took advantage of every video, the cost of education per employee would be less than $4.25 — for 10 CRCE!
Q3: I’m a staff RT in my department. Am I required to view all educational videos?
A3: No. You may watch as many or as few videos as you wish, but you will only receive CRCE credit for those videos you watched.
Q4: I’m not an AARC member. Can I still participate in AARC Explores?
A4: Yes. AARC Explores is not limited to AARC members, however, you will be responsible for keeping track of your own CRCE. Only AARC members will have their course credit added to their CRCE Transcript.
Q5: I’m part of a 10-hospital health system but am not interested in the entire series. Can I purchase a license agreement for individual videos?
A5: No. License agreements for health systems are only available for the entire video series.

AARC Explores is a compilation of the best AARC content offered in 2021. This series replaces the Current Topics in Respiratory Care annual video series.

2022 AARC Explores Pathway Guide

Pathway 1 | Available in March

Neuromodulation for Sleep Disordered Breathing

Lecturer: Meena Khan, MD

This presentation will discuss hypoglossal nerve stimulation for obstructive sleep apnea and phrenic nerve stimulation for central sleep apnea.

Pathway 2 | Available in April

New Frontiers in COPD Treatment

Lecturer: Mike Hess MPH, RRT, RPFT

The last few years have seen great new strides in COPD care, from new medications to interventional procedures. This program will review some of the latest innovations now available for people living with chronic obstruction, as well as a preview of new innovations on the horizon.

Pathway 3 | Available in May

Session 1: COVID-19 ARDS — A Distinct Type, Different From Other Forms of ARDS

Pro Lecturer: Jaspal Singh, MD, MS, MHA
Con Lecturer: Neil MacIntyre, MD

In some cases, COVID-19 can cause severe ARDS—but is COVID-19 ARDS distinct or does it differ from other forms of ARDS? Come to this session to hear two experts debate this controversial topic based on what has been learned during the pandemic.

Session 2: Understanding Silent Hypoxia in COVID-19 Patients — The Myth of Happy Hypoxics

Lecturer: Michael Lipnick, MD

Profound hypoxemia has been a common finding in COVID-19 pneumonia. Early presentations described patients with severe arterial hypoxemia without tachypnea or apparent discomfort. These patients were also said to ‘crash’ quickly and require intubation and mechanical ventilation. The term happy hypoxic littered medical journals. The issue of silent hypoxia is a well-known physiologic phenomenon related to cardiorespiratory compensation and eventual failure of these mechanisms.

Sponsored by
Masimo Logo

Pathway 4 | Available in June

Session 1: Bedside Morality — Clinical Ethics for the RT

Lecturer: James Damron, MDiv, RRT, CPFT

Have you ever questioned the right thing to do? Have you ever felt uncomfortable about the treatment plan of your patient? If you have, then this program is for you. The discipline of medical ethics has moved to the center stage of controversies in the wake of the Covid pandemic and the continued demand for individual autonomy. Don’t miss the opportunity to discuss controversial real issues, shocking real cases, and learn simple real applications to your moral distress and ethical concerns.

Session 2: Perceptions of Palliative Care — The RT’s Role in Maximizing Quality of Life

Lecturer: Shawna Strickland, PhD, RRT, FAARC

Palliative care is an important aspect of interdisciplinary, comprehensive, patient-centered care. Effective implementation of palliative care can improve health-related quality of life of patients with advanced illnesses. This presentation will focus on the RT’s role in the interdisciplinary team providing palliative care, including clinician education, patient assessment, and implementation of effective palliative care programs.

Sponsored by
Medtronic Logo

Pathway 5 | Available in July

Session 1: Has COVID-19 Changed How We Manage the Ventilated ARDS Patient?

Lecturer: Thomas Piraino, RRT, FCSRT, FAARC

The COVID-19 pandemic has made an impact in the world of mechanical ventilation, but does the presentation of the COVID-19 associated respiratory failure require a different strategy? This lecture will discuss some of the controversy surrounding COVID-19 mechanical ventilation practices and whether there is sufficient information regarding how to deliver mechanical ventilation.

Session 2: Respiratory Drive in COVID-19 Patients

Lecturer: Eddy Fan, MD, PhD

Many clinicians have described excessive respiratory drive in COVID-19 patients, but is this problematic? This lecture will discuss the impact of respiratory drive-in managing ARDS patients, and what can be done about it.

Sponsored by
Medline Logo

Pathway 6 | Available in August

Session 1: Aerosolized Surfactant Replacement Therapy: A Novel Innovaio for RDS and PARDS

Lecturer: Rob DiBlasi, RRT, RRT-NPS, FAARC

Surfactant replacement is a lifesaving therapy for pre-term infants. Liquid bolus administration via endotracheal tube has been the hallmark for surfactant administration. This lecture will discuss innovations using novel nebulizer technologies that may provide a potentially safer and more effective alternative for surfactant delivery in infants and larger children.

Session 2: You Can’t Stop Progress? Advanced Ventilator Modes in the PICU

Lecturer: Andrew Miller, MSc, RRT, RRT-ACCS, RRT-NPS, FAARC

This lecture will discuss the use of advanced (high-frequency modalities, NAVA, and APRV) in pediatric critical care. The focus will be on what we have learned so far from clinical studies, animal models, and bench studies to apply these complex modes in the PICU.

Sponsored by
Sentec Logo

Pathway 7 | Available in September

Changing the Definition and Perception of COPD

Lecturer: David Mannino, MD

The researchers working on the COPDGene project proposed, in 2019, a new way of defining COPD that expands the spirometric definition and uses other metrics, such as radiographic findings and patient symptoms. This change recognizes that COPD can have several different manifestations and phenotypes that may require different interventions. This presentation will describe these changes, their rationale, and examine how they have been applied in both research and clinical practice.

Sponsored by
Monaghan Logo

Pathway 8 | Available in October

Session 1: Current State of High Frequency Ventilation for Neonates

Lecturer: Jon Emberger, RRT, RRT-ACCS, FAARC

High frequency jet and oscillatory ventilation have been around for more than 30 years. Participants will gain a knowledge of the current indications and management strategies based on the newest evidence in the literature for using high frequency ventilation in the neonatal ICU. Several cases will be presented that underscore the optimal use of high frequency ventilation for neonates.

Session 2: Unconventional Use of NIV for Pediatric Patients with Chronic Lung Disease

Lecturer: Howard Panitch, MD

This talk with discuss strategies for the use of NIV to assist with supporting infants with chronic lung disease (BPD, Pulmonary Hypoplasia, etc.) as a bridge to growth and as to not require an invasive airway to facilitate advanced respiratory support at home.

Sponsored by
Mallinckrodt Logo

Pathway 9 | Available in November

Mechanical Ventilation in ARDS Quo Vadis?

Lecturer: Richard Kallet, MS, RRT, FAARC

Since the early descriptions of ARDS in the late 1960s, how to provide mechanical ventilation for patients with ARDS has been hotly contested. In the early days, IMV vs. Assist control and low vs high PEEP were sources of intense disagreement. A plethora of high frequency ventilation devices have come and gone. The landmark work regarding ventilator induced lung injury in the early 2000s changed how we approach ventilatory support in ARDS. ECMO has danced on the edges of ARDS management for 50 years. What is the future of mechanical ventilation in ARDS? Avoiding invasive ventilation through NIV, HFNC and ECMO are on the rise. Will driving pressure measurement and control open a new era? What about electronic muscle stimulation and diaphragm protective ventilation? This lecture asks, Quo Vadis, literally, General, where are we going?

Pathway 10 | Available in December

Airway Safety in Neonatal/Pediatrics

Lecturer: Teresa Volsko, MBA, RRT, FAARC

Infants and children have unique anatomic and physiologic considerations which make it challenging to safely achieve and maintain a patent airway. This lecture will review the equipment and techniques used to minimize the propensity for serious adverse events to occur while managing a pediatric airway.

Sponsored by
Philips Logo

Heading to the New Era

Elevate | Engage | Advocate | Educate